GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (HKSE:06127) » Definitions » 1-Year ROIIC %

Joinn Laboratories (China) Co (HKSE:06127) 1-Year ROIIC % : 27.81% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Joinn Laboratories (China) Co 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Joinn Laboratories (China) Co's 1-Year ROIIC % for the quarter that ended in Mar. 2024 was 27.81%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Joinn Laboratories (China) Co's 1-Year ROIIC % or its related term are showing as below:

HKSE:06127's 1-Year ROIIC % is ranked better than
68.72% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.11 vs HKSE:06127: 27.81

Joinn Laboratories (China) Co 1-Year ROIIC % Historical Data

The historical data trend for Joinn Laboratories (China) Co's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co 1-Year ROIIC % Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.32 22.06 6.13 8.24 787.20

Joinn Laboratories (China) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.96 28.16 35.50 787.20 27.81

Competitive Comparison of Joinn Laboratories (China) Co's 1-Year ROIIC %

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joinn Laboratories (China) Co's 1-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's 1-Year ROIIC % falls into.



Joinn Laboratories (China) Co 1-Year ROIIC % Calculation

Joinn Laboratories (China) Co's 1-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 460.1248 (Mar. 2024) - 730.3731 (Mar. 2023) )/( 6729.262 (Mar. 2024) - 7971.382 (Mar. 2023) )
=-270.2483/-1242.12
=21.76%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Joinn Laboratories (China) Co  (HKSE:06127) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Joinn Laboratories (China) Co 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Joinn Laboratories (China) Co (HKSE:06127) Business Description

Traded in Other Exchanges
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (HKSE:06127) Headlines

No Headlines